Anavex Life Sciences Corp... (AVXL)
NASDAQ: AVXL
· Real-Time Price · USD
9.91
-0.20 (-1.98%)
At close: Aug 15, 2025, 3:59 PM
10.26
3.48%
After-hours: Aug 15, 2025, 06:30 PM EDT
Anavex Life Sciences Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -54.9M | -55.17M | -55.28M | -53.07M | -51.38M | -50.19M | -51.75M | -55.73M | -58.36M | -57.29M | -54.62M | -50.99M | -47.95M | -46.85M | -44.27M | -41.95M | -37.44M | -34.19M | -32.94M |
Interest Income | 5.44M | 6.16M | 6.71M | 7.32M | 7.52M | 7.55M | 7.26M | 6.52M | 5.27M | 3.67M | 2.21M | 942.08K | 244.65K | 26.18K | 27.82K | 27.82K | 27.65K | 72.29K | 133.25K |
Pretax Income | -48.93M | -47.84M | -47.09M | -43.78M | -42.25M | -41.21M | -43.72M | -47.5M | -51.37M | -52.41M | -49.76M | -47.62M | -45.12M | -42.98M | -40.7M | -37.64M | -32.02M | -28.36M | -27.47M |
Net Income | -34.93M | -47.14M | -46.49M | -43M | -41.53M | -40.59M | -43.16M | -47.51M | -51.65M | -52.74M | -50.07M | -47.98M | -45.41M | -43.22M | -40.94M | -37.91M | -32.16M | -28.46M | -27.54M |
Selling & General & Admin | 13.05M | 11.41M | 11.58M | 11.04M | 10.85M | 11.24M | 11.33M | 12.04M | 13.35M | 13.29M | 13.32M | 13.07M | 12.05M | 11.29M | 10.61M | 9.02M | 7.54M | 6.49M | 5.97M |
Research & Development | 41.85M | 43.76M | 43.6M | 41.84M | 40.34M | 38.76M | 39.59M | 42.97M | 44.29M | 43.28M | 41.33M | 37.91M | 35.91M | 35.6M | 33.72M | 32.98M | 29.72M | 27.48M | 26.81M |
Other Expenses | n/a | n/a | n/a | 85K | 84K | 84K | 834K | 724K | 725K | 725K | -25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -74.94K |
Operating Expenses | 54.9M | 55.17M | 55.18M | 52.96M | 51.28M | 50.08M | 51.75M | 55.73M | 58.36M | 57.29M | 54.62M | 50.99M | 47.95M | 46.85M | 44.27M | 41.95M | 37.2M | 33.95M | 32.71M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 964K | 964K | 964K | 964K | n/a | 4.91K | 4.91K | 4.91K | 4.91K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 54.9M | 55.17M | 55.28M | 52.98M | 51.3M | 50.1M | 51.67M | 55.73M | 58.36M | 57.29M | 54.62M | 50.99M | 47.95M | 46.85M | 44.27M | 41.95M | 37.2M | 33.95M | 32.71M |
Income Tax Expense | -759K | -699K | -498K | -86K | -25.95K | 82.05K | 27.05K | 7K | 281.25K | 328.67K | 308.47K | 358.49K | 290.5K | 241.08K | 238.26K | 267.56K | 133.9K | 99.72K | 2.55K |
Shares Outstanding (Basic) | 85.38M | 85.07M | 84.81M | 84M | 84.53M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 75.78M | 70.59M | 68.59M | 64.3M |
Shares Outstanding (Diluted) | 85.38M | 85.07M | 84.81M | 84M | 84.53M | 82.46M | 82.08M | 79.79M | 80.88M | 78.3M | 77.98M | 76.91M | 77.44M | 76.25M | 76M | 76M | 70.59M | 68.59M | 64.3M |
EPS (Basic) | -0.57 | -0.55 | -0.55 | -0.51 | -0.5 | -0.5 | -0.54 | -0.61 | -0.67 | -0.69 | -0.66 | -0.63 | -0.59 | -0.57 | -0.55 | -0.53 | -0.47 | -0.44 | -0.44 |
EPS (Diluted) | -0.57 | -0.55 | -0.55 | -0.51 | -0.5 | -0.5 | -0.54 | -0.61 | -0.67 | -0.69 | -0.66 | -0.63 | -0.59 | -0.57 | -0.55 | -0.53 | -0.47 | -0.44 | -0.44 |
EBITDA | -71.2M | -70.1M | -69.83M | -66.52M | -43.38M | -42.35M | -43.43M | -49.57M | -53.98M | -55.02M | -54.44M | -50.81M | -47.77M | -46.85M | -44.27M | -41.95M | -37.05M | -33.8M | -32.55M |
EBIT | -49.63M | -50.46M | -50.19M | -46.88M | -45.32M | -42.35M | -43.43M | -49.57M | -53.98M | -55.02M | -54.44M | -50.81M | -47.77M | -45.53M | -42.95M | -40.63M | -35.88M | -33.95M | -32.71M |
Depreciation & Amortization | -9.27M | 4.93M | 4.56M | 3.5M | 26.25M | 25.01M | 26.41M | 41.06M | 55.35M | 54.16M | 51.4M | 47.66M | 44.67M | 42.93M | 40.24M | 37.45M | 32.27M | 29.02M | 28.08M |